scroll to top
Stuck on your essay?
Get ideas from this essay and see how your work stacks up
Word Count: 1,375
Novo Nordisk a pharmaceutical company founded in Denmark in 1923 has been a pioneer of innovative insulin delivery methods for the treatment of diabetes with brand names Levomir an injection pen that uses a pre-filled replaceable insulin cartridge and AERx an insulin inhalant While Novo Nordisk continues to be the world leader in diabetes treatment the company has expanded into other areas of research and development including human growth hormone and hemostatic products in their biopharmaceuticals Biopharmaceuticals is the method of developing products by biological process rather than chemical process often utilizing recombinant DNA or DNA that is a combination of two or more organisms Exploratorium 2006 Ypsomed Selfcare Solutions a company based in Burgdorf Switzerland was established in 2003 as a result of the split of the Burgdorf-based Disetronic Groups and is also involved in the medical appliances and equipment industry Ypsomed is involved in the development and manufacture of custom-made injection pens and compatible pen needles for the administration of self-injection solutions by patients Ypsomed Selfcare Solutions 2003-2006 The companys products can be used for a variety of applications and therapies such as insulin therapy growth hormone therapy and osteoporosis and blood glucose monitoring Ypsomed currently distributes its products primarily in Europe but expect their market to grow worldwide due to the dramatic increase in diabetes cases PriceWaterhouseCoopers is the auditor of records for these two companies Ypsomed Annual Report 2005 and Novo Nordisk Annual Report 2005 Novo Nordisk Financial Data-2005 Annual Report Novo Nordisk was the first Scandinavian company to be quoted on the New York Stock Exchange and is now an international company with representation in 69 countries Wikipedia 2005 The 2005 annual report states the company had a turnover of DKK 338 billion or approximately 45 billion EUR X-rates 2006 Total sales for diabetes products was DKK 24012 million while consolidated sales were DKK 33760 million for a 16 growth over prior year Novo Nordisk 2005 Operating profit margin
@Kibin is a lifesaver for my essay right now!!
- Sandra Slivka, student @ UC Berkeley
Wow, this is the best essay help I've ever received!
- Camvu Pham, student @ U of M
If I'd known about @Kibin in college, I would have gotten much more sleep
- Jen Soust, alumni @ UCLA